Skip to main content

Table 3 Correlation analysis of Caveolin-1 expression with clinical and pathological variables in primary breast cancer patients. Included are only cases in both Caveolin-1 expression status as well as clinical and pathological variable were available

From: Caveolin-1 expression in benign and malignant lesions of the breast

clinical and pathological variables   Caveolin-1 positive/all tumours (%) p (χ2-test)
ER negative 15/41 (36.6) 0.204
  positive 16/64 (25.0)  
PR negative 20/65 (30.8) 0.721
  positive 11/40 (55.0)  
HER2 negative 28/98 (28.6) 0.320
  positive 4/9 (44.4)  
Mib1 < 20% 15/39 (38.4) 0.143
  ≥ 20% 17/68 (25.0)  
pT-stage T1/2 22/80 (27.5) 0.476
  T3/4 10/29 (34.5)  
pN-stage negative 18/60 (30.0) 0.981
  positive 14/47 (29.8)  
pM-stage negative 29/94 (30.9) 0.391
  positive 3/15 (20.0)  
tumour grade 1 1/6 (16.7) 0.740
  2 17/59 (28.8)  
  3 14/44 (31.8)  
multifocality no 19/83 (22.9) 0.008
  yes 13/26 (50.0)  
inflammatory no 30/102 (29.4) 0.962
  yes 2/7 (28.6)  
lymphangiosis carcinomatosa no 22/82 (26.8) 0.312
  yes 10/27 (37.0)